Inventor · disambiguated record
Gudrun Schiedner
Also filed as: SCHIEDNER GUDRUN
7 granted patents·3 pending applications·396 citations·filing 1998–2018
85Inventor score
Files withSCHIEDNER GUDRUN3CEVEC PHARMACEUTICALS GMBH2BAYLOR COLLEGE MEDICINE1Cevec Pharmaceutical GmbH1VLAAMS INTERUNIV INST BIOTECH1
Top patents by PatentIndex Score
10 records- 0194US5981225AGene transfer vector, recombinant adenovirus particles containing the same, method for producing the same and method of use of the sameBAYLOR COLLEGE MEDICINE·Filed 1998·Granted Nov 9, 1999·296 cites·36 claims
- 0292US6558948B1Permanent amniocytic cell line, its production and use for the production of gene transfer vectorsFiled 2000·Granted May 6, 2003·75 cites·24 claims
- 0388US9315773B2Method for the production of permanent human cell linesCEVEC PHARMACEUTICALS GMBH·Filed 2014·Granted Apr 19, 2016·10 cites·21 claims
- 0483US7238346B2High capacity recombinant adenoviral vector for treatment of hemophilia AVLAAMS INTERUNIV INST BIOTECH·Filed 2002·Granted Jul 3, 2007·13 cites·5 claims
- 0569US8936908B2Method for the production of permanent human cell linesSCHIEDNER GUDRUN·Filed 2006·Granted Jan 20, 2015·1 cites·11 claims
- 0665US9371512B2Method for the production of permanent human cell linesSCHIEDNER GUDRUN·Filed 2010·Granted Jun 21, 2016·1 cites·8 claims
- 0744US2015259387A1Production of a hcmv based vaccine in human amniocyte cell linesCEVEC PHARMACEUTICALS GMBH·Filed 2013·Application pending·0 cites
- 0840US2005196751A1Adenoviral vector-mediated delivery of modified steroid hormone receptors and related products and methodsFiled 2001·Application pending·0 cites
- 0939US11193156B2Recombinant glycoproteins with reduced antennary fucosylationCevec Pharmaceutical GmbH·Filed 2018·Granted Dec 7, 2021·0 cites·15 claims
- 1033US2013344569A1Permanent human cell lines for the production of influenza virusesSCHIEDNER GUDRUN·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Gudrun Schiedner files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →